FKBP10 Regulates Protein Translation to Sustain Lung Cancer Growth.
暂无分享,去创建一个
P. Baldi | A. Charollais | R. Coppari | Fedor Bezrukov | A. Santinelli | M. Samad | G. Konstantinidou | O. Panasenko | M. Collart | T. Biscotti | M. Luchetti | G. Ramadori | Ebru Aras | R. M. Ioris | Xavier Brenachot | R. Ioris | Z. Villányi | Raquel Firnkes | George E Allen
[1] D. Foell,et al. S100A9 extends lifespan in insulin deficiency , 2019, Nature Communications.
[2] Gang Chen,et al. Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer , 2019, Oncology reports.
[3] P. Baldi,et al. Light Entrains Diurnal Changes in Insulin Sensitivity of Skeletal Muscle via Ventromedial Hypothalamic Neurons. , 2019, Cell reports.
[4] K. Kerr,et al. Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC , 2019, Nature Reviews Clinical Oncology.
[5] James C. Hu,et al. The Gene Ontology Resource: 20 years and still GOing strong , 2019 .
[6] L. Montanaro,et al. The Ribosome Biogenesis—Cancer Connection , 2019, Cells.
[7] The Gene Ontology Consortium,et al. The Gene Ontology Resource: 20 years and still GOing strong , 2018, Nucleic Acids Res..
[8] J. Wolchok,et al. Putting the Immunologic Brakes on Cancer , 2018, Cell.
[9] L. Paz-Ares,et al. KRAS-Mutant non-small cell lung cancer: From biology to therapy. , 2018, Lung cancer.
[10] Iñigo Apaolaza,et al. CANCERTOOL: A Visualization and Representation Interface to Exploit Cancer Datasets. , 2018, Cancer research.
[11] A. Lánczky,et al. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets , 2018, Scientific Reports.
[12] S. Vicent,et al. KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target , 2018, Molecular Cancer.
[13] Fabio Lauria,et al. riboWaltz: Optimization of ribosome P-site positioning in ribosome profiling data , 2017, bioRxiv.
[14] Jaeho Bae,et al. Enhancement of antitumor immunity by combination of anti-CTLA-4 antibody and radioimmunotherapy through the suppression of Tregs. , 2017, Oncology letters.
[15] M. Yamauchi,et al. FKBP65-dependent peptidyl-prolyl isomerase activity potentiates the lysyl hydroxylase 2-driven collagen cross-link switch , 2017, Scientific Reports.
[16] P. Baldi,et al. SIRT6 Suppresses Cancer Stem-like Capacity in Tumors with PI3K Activation Independently of Its Deacetylase Activity , 2017, Cell reports.
[17] J. Settleman,et al. Proline Starvation Induces Unresolved ER Stress and Hinders mTORC1-Dependent Tumorigenesis. , 2016, Cell metabolism.
[18] Kol Jia Yong,et al. Targeting SALL4 by entinostat in lung cancer , 2016, Oncotarget.
[19] Song Wu,et al. FK506 Binding Protein 10 Is Overexpressed and Promotes Renal Cell Carcinoma , 2016, Urologia Internationalis.
[20] L. Paz-Ares,et al. Current Challenges in Cancer Treatment. , 2016, Clinical therapeutics.
[21] Reuven Agami,et al. Tumour-specific proline vulnerability uncovered by differential ribosome codon reading , 2016, Nature.
[22] Gunnar Rätsch,et al. RiboDiff: detecting changes of mRNA translation efficiency from ribosome footprints , 2015, bioRxiv.
[23] R. Coppari,et al. Enhanced insulin sensitivity in skeletal muscle and liver by physiological overexpression of SIRT6 , 2015, Molecular metabolism.
[24] G. Massonnet,et al. Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists , 2013, Nature.
[25] N. Sonenberg,et al. Targeting the translation machinery in cancer , 2015, Nature Reviews Drug Discovery.
[26] Steven L Salzberg,et al. HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.
[27] R. Coppari,et al. Diet-Induced Unresolved ER Stress Hinders KRAS-Driven Lung Tumorigenesis , 2015, Cell metabolism.
[28] Michael N. Hall,et al. mTORC1 mediated translational elongation limits intestinal tumour initiation and growth , 2014, Nature.
[29] Brendan H. Lee,et al. Connective tissue alterations in Fkbp10-/- mice. , 2014, Human molecular genetics.
[30] R. Weinberg,et al. Tackling the cancer stem cells — what challenges do they pose? , 2014, Nature Reviews Drug Discovery.
[31] A. Koromilas,et al. Translational Control during Endoplasmic Reticulum Stress beyond Phosphorylation of the Translation Initiation Factor eIF2α* , 2014, The Journal of Biological Chemistry.
[32] P. Rosenstiel,et al. XIAP variants in male Crohn's disease , 2014, Gut.
[33] A. Mes-Masson,et al. FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcome. , 2013, International journal of oncology.
[34] Shu-Bing Qian,et al. Cotranslational response to proteotoxic stress by elongation pausing of ribosomes. , 2013, Molecular cell.
[35] I. Wistuba,et al. RHOA-FAK is a required signaling axis for the maintenance of KRAS-driven lung adenocarcinomas. , 2013, Cancer discovery.
[36] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[37] P. Beighton,et al. Mutations in FKBP10 Cause Recessive Osteogenesis Imperfecta and Bruck Syndrome , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[38] P. Byers,et al. Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. , 2010, American journal of human genetics.
[39] P. Byers,et al. Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. , 2010, American journal of human genetics.
[40] C. Iacobuzio-Donahue,et al. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. , 2010, Journal of the National Cancer Institute.
[41] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[42] D. Steindler,et al. Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer. , 2009, Cancer research.
[43] K. Yasumoto,et al. Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer , 2009, General thoracic and cardiovascular surgery.
[44] H. Burris,et al. Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs , 2009, Oncogene.
[45] Nicholas T. Ingolia,et al. Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling , 2009, Science.
[46] Y. Ishikawa,et al. The Rough Endoplasmic Reticulum-resident FK506-binding Protein FKBP65 Is a Molecular Chaperone That Interacts with Collagens* , 2008, Journal of Biological Chemistry.
[47] K. Myers,et al. The oncofetal protein, 5T4, is a suitable target for antibody-guided anti-cancer chemotherapy with calicheamicin. , 2008, International journal of oncology.
[48] Daniel Birnbaum,et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.
[49] A. Bhandoola,et al. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. , 2007, Cell stem cell.
[50] A. Cheung,et al. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential , 2007, Leukemia.
[51] J. Dick,et al. Cancer stem cells: lessons from leukemia. , 2005, Trends in cell biology.
[52] Danila Coradini,et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. , 2005, Cancer research.
[53] Dong Wang,et al. Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.
[54] T. Ørntoft,et al. Human FK506 Binding Protein 65 Is Associated with Colorectal Cancer*S , 2005, Molecular & Cellular Proteomics.
[55] H. Varmus,et al. KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib , 2005, PLoS medicine.
[56] T. Honjo,et al. PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells. , 2004, International immunology.
[57] G. Dontu,et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.
[58] H. Varmus,et al. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. , 2001, Genes & development.
[59] C. Holding,et al. Human embryonic genes re-expressed in cancer cells , 2001, Oncogene.
[60] E. Davis,et al. Developmental regulation of FKBP65. An ER-localized extracellular matrix binding-protein. , 2000, Molecular biology of the cell.
[61] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[62] G. Rall,et al. Measles Virus Spread between Neurons Requires Cell Contact but Not CD46 Expression, Syncytium Formation, or Extracellular Virus Production , 2000, Journal of Virology.
[63] M. Ashburner,et al. The Gene Ontology Consortium , 2000 .
[64] J. Allison,et al. Enhancement of Antitumor Immunity by CTLA-4 Blockade , 1996, Science.
[65] M. Caligiuri,et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.